Adipose-derived resistin and gut-derived resistin-like molecule-β selectively impair insulin action on glucose production

Michael W. Rajala, Silvana Obici, Philipp E. Scherer, Luciano Rossetti

Research output: Contribution to journalArticle

457 Citations (Scopus)

Abstract

The adipose-derived hormone resistin is postulated to link obesity to insulin resistance and diabetes. Here, the infusion of either resistin or the resistin-like molecule-β (RELMβ) rapidly induced severe hepatic but not peripheral insulin resistance. In the presence of physiologic hyperinsulinemia, the infusion of purified recombinant resistin, increasing circulating resistin levels by approximately twofold to 15-fold, inhibited glucose metabolism such that lower rates of glucose infusion were required to maintain the plasma glucose concentration at basal levels. The effects of resistin and RELMβ on in vivo insulin action were completely accounted for by a marked increase in the rate of glucose production. These results support the notion that a novel family of fat- and gut-derived circulating proteins modulates hepatic insulin action.

Original languageEnglish (US)
Pages (from-to)225-230
Number of pages6
JournalJournal of Clinical Investigation
Volume111
Issue number2
DOIs
StatePublished - Jan 2003

Fingerprint

Resistin
Insulin
Glucose
Insulin Resistance
Liver
Hyperinsulinism
Vascular Resistance
Obesity
Fats
Hormones

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Adipose-derived resistin and gut-derived resistin-like molecule-β selectively impair insulin action on glucose production. / Rajala, Michael W.; Obici, Silvana; Scherer, Philipp E.; Rossetti, Luciano.

In: Journal of Clinical Investigation, Vol. 111, No. 2, 01.2003, p. 225-230.

Research output: Contribution to journalArticle

@article{252ac2523770491984047b3f9f5aa428,
title = "Adipose-derived resistin and gut-derived resistin-like molecule-β selectively impair insulin action on glucose production",
abstract = "The adipose-derived hormone resistin is postulated to link obesity to insulin resistance and diabetes. Here, the infusion of either resistin or the resistin-like molecule-β (RELMβ) rapidly induced severe hepatic but not peripheral insulin resistance. In the presence of physiologic hyperinsulinemia, the infusion of purified recombinant resistin, increasing circulating resistin levels by approximately twofold to 15-fold, inhibited glucose metabolism such that lower rates of glucose infusion were required to maintain the plasma glucose concentration at basal levels. The effects of resistin and RELMβ on in vivo insulin action were completely accounted for by a marked increase in the rate of glucose production. These results support the notion that a novel family of fat- and gut-derived circulating proteins modulates hepatic insulin action.",
author = "Rajala, {Michael W.} and Silvana Obici and Scherer, {Philipp E.} and Luciano Rossetti",
year = "2003",
month = "1",
doi = "10.1172/JCI200316521",
language = "English (US)",
volume = "111",
pages = "225--230",
journal = "Journal of Clinical Investigation",
issn = "0021-9738",
publisher = "The American Society for Clinical Investigation",
number = "2",

}

TY - JOUR

T1 - Adipose-derived resistin and gut-derived resistin-like molecule-β selectively impair insulin action on glucose production

AU - Rajala, Michael W.

AU - Obici, Silvana

AU - Scherer, Philipp E.

AU - Rossetti, Luciano

PY - 2003/1

Y1 - 2003/1

N2 - The adipose-derived hormone resistin is postulated to link obesity to insulin resistance and diabetes. Here, the infusion of either resistin or the resistin-like molecule-β (RELMβ) rapidly induced severe hepatic but not peripheral insulin resistance. In the presence of physiologic hyperinsulinemia, the infusion of purified recombinant resistin, increasing circulating resistin levels by approximately twofold to 15-fold, inhibited glucose metabolism such that lower rates of glucose infusion were required to maintain the plasma glucose concentration at basal levels. The effects of resistin and RELMβ on in vivo insulin action were completely accounted for by a marked increase in the rate of glucose production. These results support the notion that a novel family of fat- and gut-derived circulating proteins modulates hepatic insulin action.

AB - The adipose-derived hormone resistin is postulated to link obesity to insulin resistance and diabetes. Here, the infusion of either resistin or the resistin-like molecule-β (RELMβ) rapidly induced severe hepatic but not peripheral insulin resistance. In the presence of physiologic hyperinsulinemia, the infusion of purified recombinant resistin, increasing circulating resistin levels by approximately twofold to 15-fold, inhibited glucose metabolism such that lower rates of glucose infusion were required to maintain the plasma glucose concentration at basal levels. The effects of resistin and RELMβ on in vivo insulin action were completely accounted for by a marked increase in the rate of glucose production. These results support the notion that a novel family of fat- and gut-derived circulating proteins modulates hepatic insulin action.

UR - http://www.scopus.com/inward/record.url?scp=0037241112&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037241112&partnerID=8YFLogxK

U2 - 10.1172/JCI200316521

DO - 10.1172/JCI200316521

M3 - Article

VL - 111

SP - 225

EP - 230

JO - Journal of Clinical Investigation

JF - Journal of Clinical Investigation

SN - 0021-9738

IS - 2

ER -